antibodies News

(Raleigh, NC) -- ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of AmyJet Scientific as its new distributor in China.

ImmunoReagents, a manufacturer of high quality polyclonal antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Bioleague as its new distributor in Germany.

Consider novel linker strategy techniques to increase efficacy of ADC products

ImmunoReagents, a manufacturer of high quality secondary antibodies used by researchers, pharmaceutical and biotechnology companies, has announced the appointment of Funakoshi as its new distributor for Japan.

New report: Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

Vrisko limited is now providing custom antibody services produced by the hybridoma technology. Our company has reached aggreement with leader biotechnology companies to provide the best monoclonal antibody services.

In Cell Art, a biotechnology company specialising in the development of innovative vaccines and antibodies, has announced today the launch of a US$33.1 million research-and-development project — the RN Armor Vax Consortium.

2B Scientific, a leading UK distributor of life science reagents now supplies antibodies, reagents and kits from IMGENEX Corporation.

While the gold price keeps setting new records, nanoparticles from pure gold are also gaining importance in biotechnology. Particular GmbH from Germany now uses a laser method to produce them with high purity and conjugate them with high efficiency.

Part two of the article series on your immune system focuses in on changes that can occur as we age. It's important to know what can happen, and what can further weaken your immune system. Let's get to it.

And so begins my multi-part article on a very important subject: your immune system; the things inside you that attack foreign invaders and prevent disease from setting in. Before I get to the ways you can boost your own immunity,

Randox Life Sciences has developed and manufactured a wide range of products including high quality, cost effective recombinant proteins, polyclonal antibodies and conjugates targeting drugs of abuse, steroids, hormones and biochemical markers.

Featuring 12 conference programs within 4 streams focused on the current trends and science in antibody engineering and development (PEGSummit.com).

Randox Life Sciences is a recognised primary manufacturer of high quality, cost-effective human recombinant proteins, recombinant antibody fragments and polyclonal and monoclonal antibodies to classic and novel targets.

Therapeutic antibodies are central to pharmaceutical development; needless to say, emphasis is continually on developing new methods and improving those already in place. Play an active role in the war against disease – register online today!

tebu-bio is pleased to announce the renewal of their agreement with Advanced Biotechnologies for the distribution of their products throughout Europe.

UCB seeking to understand cell signalling mechanisms of therapeutic antibodies enabling identification of biomarkers

Being the first in the industry to provide a whole suite of reagents and assay kits for the advancement of MS research, AnaSpec is pleased to announce the release of the mouse monoclonal Anti-MOG (1-125).

Although the therapeutic vaccine market has experienced a range of setbacks and disappointments, technological evolution should ultimately enable therapeutic vaccines to make similar commercial breakthroughs as monoclonal antibodies, notes Kalorama.

AbboMax offers nine novel anti- histone H3 antibodies specific for a mono-, di-, or tri-methylated state of Lys4, Lys9, and Lys27 for the epigenetics research. .

Bharatbook added a new report on "Therapeutic Monoclonal Antibodies: World Market 2010-2025" which gives the potential applications and prospects on worldwide Therapeutic Monoclonal Antibodies.

Oncology has emerged as the third largest segment in drug treatment, largely due to the growth of adjunctive therapies and high-cost of effective biotherapy. Sales have increased from $30 billion in 2005 to $65 billion forecasted for 2010.

Because DNA vaccines generate cell-mediated immunity, the hope is that they will be effective against difficult viruses, even in cases where standard vaccines have failed to work.

The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008.

Bharatbook added a new report on "Monoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025" explains how this market will develop, and where the opportunities will lie.

Randox Life Sciences is a recognised primary manufacturer of high quality, cost effective monoclonal antibodies to both classic and novel targets.

MedImmune has agreed to license the rights to develop Trellis Bioscience's monoclonal antibody products for the treatment of respiratory syncytial virus (RSV).

Multiple Sclerosis (MS) is a possibly the weakening ailment, where one’s immune system slowly deteriorates as the protective cover of one’s nerves worsens by each passing day.

Izon Science unveil latest breakthrough in nanoparticle analysis at 2010 BIO International Convention in Chicago

New Pharmaceuticals research report from Business Insights is now available from Fast Market Research

Recently published research from Business Insights, "Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging technologies and new therapeutic candidates", is now available at Fast Market Research

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, announce that they have launched the first TMEM97 antibody onto the market.

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, have launched new Histone antibodies for use in DNA repair research.

Novus Biologicals, an international supplier of antibodies, biological products and materials to various scientific sectors, have launched a new HIF Prolyl Hydroxylase antibody for use in research

New approach automates verification, labelling and printing of high value products in tubes. A breakthrough in labelling technology promises a 450% increase in throughput for leading antibody supplier, Abcam plc.

Bio-Synthesis, Inc. provides custom products for researchers and pharmaceutical companies

The new uses and benefits of anti-drug antibodies, examined by Bio-Synthesis, Inc.

Bio-Synthesis has teamed up with BioConference Live for a revolutionary event. BioConference Live is a free, online-only conference for the life sciences and laboratory science community.

tebu-bio announces the launch of their new website, providing European Life Sciences Researchers with a powerful tool to help them in their research

Bharatbook.com included a new report on "Monoclonal Antibodies in Cancer Therapy " which depicts about the significant commercial opportunities with developing technologies and innovative products.

Pre-clinical data on MM-121 with selected cancer therapies and their combined effect in different cancer models, also in combination with targeted cancer therapies. Pre-clinical data on MM-111 as a montherapy to treat tumors overexpressing ErbB2.

AnaSpec has introduced a line of secondary antibodies and streptavidin conjugated to the newest member of the HiLyte Fluor™ family - HiLyte Fluor™ 594 (Ex/Em=593/616 nm)

IMGENEX, a premiere biotech company specialized in antibody production for Research and Development, is pleased to announce a special 30% discount offer to its valued customers on a wide selection of antibodies.

In February 2008, Assay Designs™ launched the Hsp70 High Sensitivity EIA Kit, the first commercially available EIA kit for the accurate and specific quantification of inducible Hsp70 in serum and plasma samples from human, mouse, and rat origin.

Biotechnology companies are focusing on the development of novel biomarkers to overcome the limitations of current diagnostic tests for cancer, reports Genetic Engineering and Biotechnology News (GEN).

GTCbio just announced its holding the annual Modern Drug Discovery and Development Summit taking place on October 15-17, 2008 in San Diego, CA.

23RD - 25TH JANUARY 2008, BSG CONFERENCE CENTRE, LONDON, UK A must-attend event that will provide an excellent opportunity to network, enhance your company’s profile and keep you up-to-date on the latest issues in the market

Cambridge Research Biochemicals (CRB) has signed an agreement with Panagene to become the UK distributor for high purity peptide nucleic acids (PNA) oligomers. PNAs have many applications in bio-procedures, diagnostics, and anti-gene therapies.